348 related articles for article (PubMed ID: 34446369)
1. Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.
Mahal BA; Gerke T; Awasthi S; Soule HR; Simons JW; Miyahira A; Halabi S; George D; Platz EA; Mucci L; Yamoah K
Eur Urol Oncol; 2022 Feb; 5(1):18-29. PubMed ID: 34446369
[TBL] [Abstract][Full Text] [Related]
2. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.
Dovey ZS; Nair SS; Chakravarty D; Tewari AK
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1340. PubMed ID: 33599076
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in Black men with prostate cancer: A literature review.
Lillard JW; Moses KA; Mahal BA; George DJ
Cancer; 2022 Nov; 128(21):3787-3795. PubMed ID: 36066378
[TBL] [Abstract][Full Text] [Related]
4. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
5. Trends in mortality among Black and White men with prostate cancer in Massachusetts and Pennsylvania: Race and neighborhood socioeconomic position.
Iyer HS; Gomez SL; Chen JT; Trinh QD; Rebbeck TR
Cancer; 2021 Jul; 127(14):2525-2534. PubMed ID: 33798264
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in prostate cancer among black men: epidemiology and outcomes.
Chowdhury-Paulino IM; Ericsson C; Vince R; Spratt DE; George DJ; Mucci LA
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):397-402. PubMed ID: 34475523
[TBL] [Abstract][Full Text] [Related]
8. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care.
Nyame YA; Cooperberg MR; Cumberbatch MG; Eggener SE; Etzioni R; Gomez SL; Haiman C; Huang F; Lee CT; Litwin MS; Lyratzopoulos G; Mohler JL; Murphy AB; Pettaway C; Powell IJ; Sasieni P; Schaeffer EM; Shariat SF; Gore JL
Eur Urol; 2022 Oct; 82(4):341-351. PubMed ID: 35367082
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer.
Krimphove MJ; Cole AP; Fletcher SA; Harmouch SS; Berg S; Lipsitz SR; Sun M; Nabi J; Nguyen PL; Hu JC; Kibel AS; Choueiri TK; Kluth LA; Trinh QD
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):125-136. PubMed ID: 30171227
[TBL] [Abstract][Full Text] [Related]
10. Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.
Esdaille AR; Ibilibor C; Holmes A; Palmer NR; Murphy AB
Urology; 2022 May; 163():90-98. PubMed ID: 34582887
[TBL] [Abstract][Full Text] [Related]
11. The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models.
Woods-Burnham L; Basu A; Cajigas-Du Ross CK; Love A; Yates C; De Leon M; Roy S; Casiano CA
Prostate; 2017 Dec; 77(16):1601-1608. PubMed ID: 29030865
[TBL] [Abstract][Full Text] [Related]
12. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.
Chornokur G; Dalton K; Borysova ME; Kumar NB
Prostate; 2011 Jun; 71(9):985-97. PubMed ID: 21541975
[TBL] [Abstract][Full Text] [Related]
13. Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology.
Campi R; Brookman-May SD; Subiela Henríquez JD; Akdoğan B; Brausi M; Klatte T; Langenhuijsen JF; Linares-Espinos E; Marszalek M; Roupret M; Stief CG; Volpe A; Minervini A; Rodriguez-Faba O
Eur Urol Focus; 2019 Nov; 5(6):1029-1057. PubMed ID: 29661588
[TBL] [Abstract][Full Text] [Related]
14. Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU).
Brookman-May SD; Campi R; Henríquez JDS; Klatte T; Langenhuijsen JF; Brausi M; Linares-Espinós E; Volpe A; Marszalek M; Akdogan B; Roll C; Stief CG; Rodriguez-Faba O; Minervini A
Eur Urol Focus; 2019 Sep; 5(5):756-787. PubMed ID: 29576530
[TBL] [Abstract][Full Text] [Related]
15. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer metastasis and health disparities: a systematic review.
Liadi Y; Campbell T; Dike P; Harlemon M; Elliott B; Odero-Marah V
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):183-191. PubMed ID: 37046071
[TBL] [Abstract][Full Text] [Related]
17. Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.
Seibert TM; Garraway IP; Plym A; Mahal BA; Giri V; Jacobs MF; Cheng HH; Loeb S; Helfand BT; Eeles RA; Morgan TM
Eur Urol; 2023 Mar; 83(3):241-248. PubMed ID: 36609003
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Survival Outcomes Among Black and White Patients with Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysis.
Yang J; Xiong X; Zheng W; Liao X; Xu H; Yang L; Wei Q
Eur Urol Open Sci; 2024 Mar; 61():10-17. PubMed ID: 38384441
[TBL] [Abstract][Full Text] [Related]
19. Disparities in prostate cancer incidence and mortality rates: Solvable or not?
Badal S; Aiken W; Morrison B; Valentine H; Bryan S; Gachii A; Ragin C
Prostate; 2020 Jan; 80(1):3-16. PubMed ID: 31702061
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Patient Race, Ethnicity, Socioeconomic Status, and Educational Attainment in Prostate Cancer Treatment Randomised Trials-Is the Evidence Base Applicable to the General Patient Population?
Patki S; Aquilina J; Thorne R; Aristidou I; Rodrigues FB; Warren H; Bex A; Kasivisvanathan V; Moore C; Gurusamy K; Emberton M; Best LMJ; Tran MGB
Eur Urol Open Sci; 2023 Aug; 54():56-64. PubMed ID: 37545851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
